Israeli pride: the leading patent firm in Europe, the Middle East, and Africa is from Israel

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Israeli pride: the leading patent firm in Europe, the Middle East, and Africa is from Israel

Sponsored by

23LuzzattoGroupIsrael.png

The Luzzatto Group talks about being the leading patent firm in Europe, the Middle East, and Africa

The life sciences team of The Luzzatto Group won two prestigious awards from the international ranking LMG Life Science—the "Israeli Firm of the Year " award and the "Firm of the Year in Patent Strategy and Management" award, selected between firms in the Europe, Middle East, and Africa (EMEA) region. Dr. Kfir Luzzatto, president of the Group: "In these days of boycotts of Israeli science and research, this is a refreshing breath of fresh air. We are proud and excited to receive the two prizes."

The Luzzatto Group, the oldest intellectual property group in Israel, attained a double and extraordinary international achievement when its life sciences team was selected by the award committee of the LMG Life Sciences Global Ranking to receive the "Firm of the Year in Israel" award as well as the "Firm of the Year in Patent Strategy and Management" award, given to a single firm in the Europe, Middle East, and Africa (EMEA) region.

This is one of the most prestigious and well-respected awards in the arena of law firms and intellectual property firms worldwide, specializing in, among other things, the life sciences industries. It is intended to publicly highlight the unique contribution and professionalism of the patent attorneys and lawyers who engaged in life sciences legal practice during the 12 months preceding the announcement of the award. The ranking-based award is based on examining professional work in the field of life sciences, such as filing patents and managing litigation cases, and rankings of the patent attorneys behind them.

The ceremony occurred in London last Thursday, May 16, 2024, at a unique gala evening.

"We are proud and excited to receive the two awards that reflect the great expertise of our life sciences team in the fields of life sciences, biotechnology, digital health, pharma, and medical devices," said Dr. Kfir Luzzatto, patent attorney and president of the Group, which is currently celebrating its 155th anniversary.

"Our patent attorneys are considered world-renowned experts in the field of Life Sciences and MedTech," he added and noted that the Group represents many multinational pharmaceutical companies operating in Israel and hundreds of Israeli companies, including many start-ups in these fields. Only last April, the Group won a significant Novartis case concerning Patent Term Extension (PTE), which has broad implications for pharmaceutical patent holders.

"Precisely in these depressing days of wild demonstrations against Israel on campuses in the USA and a silent boycott of Israeli researchers and scientists, these awards are a refreshing breath of fresh air," stressed Dr. Luzzatto.

Tamar Luzzatto, a lawyer and head of business development and marketing of the Group, stated that in March, the candidates' final list (the "shortlist") for the international and prestigious award was released. The Group's life sciences team was shortlisted in five categories, the largest number of any other firm in Israel.

She further stated that the Group's professionals who were personally included in the award lists are Dr. Kfir Luzzatto, in the category " Professional of the Year in Patent Litigation," and Prof. Emanuel Manzurola, in the category "Professional of the Year in Patent Management and Patent Strategy."

She emphasized that awards were given based on market evaluation and analysis, according to the Group's direct contribution to clients and independent research, including peer feedback and client reviews.

more from across site and SHARED ros bottom lb

More from across our site

In his first interview since leaving Weil Gotshal & Manges, Chris Henry explains why he returned to Latham and how he plans to bolster its tech disputes offering
As GTA VI underlines the extraordinary value of gaming franchises, lawyers at Clifford Chance say investors need to know the IP behind their next deal can deliver the growth they are paying for
As ‘big law’ invests in IP litigation, trial firms are emerging as a valuable source of seasoned courtroom talent
Six hires across the IP spectrum reflect Orrick’s efforts to better serve tech clients across the IP lifecycle
David Stone, partner at White & Case, argues that the government’s planned reforms will modernise and futureproof UK design law, but leave two of the thorniest problems unresolved
Max Scott will join the firm’s IP transactions group in California, becoming the latest Weil IP partner to secure their future
Yonatan Drori, attorney at Drori-Stav IP in Israel, explains why foreign counsel must treat Israel’s patent disclosure requirements as an ongoing obligation, rather than a one-off formality
From Japan to Southeast Asia, domestic and regional firms picked up some of the biggest prizes, while key foreign players maintained momentum
Earlier this month, Managing IP had exclusively reported that the French arm of Taylor Wessing was minded to pull out of the deal
Our latest podcast examines how Weil’s IP practice evolved, where its practitioners could (and will) go next, and which firms and markets stand to benefit from the redistribution of talent
Gift this article